CLASS II Drug recall · Reported 21 Sep 2016 · FDA Enforcement Report

DOBUTamine Injection, USP 250 mg/ Vial, For IV Use Only recalled

Hospira is recalling DOBUTamine Injection, USP 250 mg/ Vial, For IV Use Only, Must be Diluted Prior to Use, 5, distributed nationwide in the US. The recall was initiated on 15 Aug 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: 52175DD, Exp 01 Oct 2016
Quantity recalled24000 vials

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1500-2016
FDA event ID
74707
Recalling firm
Hospira, Lake Forest, IL
Classification
Class II
Status
Terminated
Recall initiated
15 Aug 2016
FDA classified
14 Sep 2016
Reported
21 Sep 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Particulate Matter

Timeline

15 Aug 2016Recall initiated by company
14 Sep 2016Classified by FDA+30 days
21 Sep 2016Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Discoloration: Firm received complaints of product discoloration and particulates.

Product as listed by the FDA

DOBUTamine Injection, USP 250 mg/20 mL, 20 mL Vial, For IV Use Only, Must be Diluted Prior to Use, (12.5 mg per mL), Rx Only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-2025-20

Where it was distributed

Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units. 30 units returned by customer and destroyed internally.

Nationwide Puerto Rico

Questions about this recall

Is DOBUTamine Injection, USP 250 mg/ Vial, For IV Use Only, Must be Diluted Prior to Use, 5 recalled?

Yes. Hospira recalled DOBUTamine Injection, USP 250 mg/ Vial, For IV Use Only, Must be Diluted Prior to Use, 5 on 15 Aug 2016. The recall is Class II and its status is Terminated. Recall number D-1500-2016.

Why was it recalled?

Discoloration: Firm received complaints of product discoloration and particulates.

Which lots are affected?

Lot #: 52175DD, Exp 01 Oct 2016

Where was it sold?

Product was distributed nationwide. 23700 units distributed to US and Puerto Rico, and Bahamas was 300 units. 30 units returned by customer and destroyed internally.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Hospira

All 225

Other Dobutamine recalls

All 3
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDOBUTamine Injection, USP, 250 mg/ 5 mg/mL) per Single-dose recalledDobutaminePfizerOtherNationwide
DrugCLASS IDOBUTamine Injection, USP, 250 mg per Single-dose Fliptop Vial recalledDobutamineHospiraParticulate MatterNationwide